DLS MD Portal

Curated by Signal

Provider of a laboratory test reports management app for healthcare providers

Overview

Provider of a laboratory test reports management app for healthcare providers. The company has designed an app called DLS MD Portal that assist healthcare providers to access laboratory test results on a real-time basis. The platform can be used to share lab reports with patients as well. Users can filter patients' reports based on patients' information. The app is compatible with IOS as well as Andriod devices.

Key facts

Founded: 2017
Headquarters: Honolulu, United States
Stage: Sign up to view
Industry: Health Technology

Business model

4 products and services: Sign up to view

Open roles

1 role

Various Medical Technologist management position
Honolulu, HI · On-site · Full-time

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

MyLifeIQ
Provider of SaaS-based virtual care platform for healthcare organizations
Health TechnologyDallas, United States
Dope Loans
Provider of an online directory of cannabis-friendly lenders
Health TechnologyWest Sacramento, United States
Noble Direct
Provider of billing and claims management software solutions for hospitals
Health TechnologyDeerfield Beach, United States

About DLS MD Portal

What does DLS MD Portal do?

Provider of a laboratory test reports management app for healthcare providers.

Where is DLS MD Portal headquartered?

DLS MD Portal is headquartered in Honolulu, United States.

When was DLS MD Portal founded?

DLS MD Portal was founded in 2017.

Which sector is DLS MD Portal in?

DLS MD Portal operates in Health Technology.

Who are DLS MD Portal's competitors?

Companies similar to DLS MD Portal include MyLifeIQ, Dope Loans, and Noble Direct.

Is DLS MD Portal hiring?

Yes. DLS MD Portal has 1 open role listed on Vanberra Signal.